Patent Landscape and Claims Analysis for US Patent 12,011,424
What is the scope of US Patent 12,011,424?
US Patent 12,011,424 covers a novel pharmaceutical composition and method related to a specific class of drugs. The patent primarily discloses:
- Inventive Claims: The patent claims RIGHTS over a new chemical entity (NCE) or a specific formulation including the drug.
- Uses: It describes the application of the compound for treatment of certain diseases.
- Methods of Production: It details synthetic routes and manufacturing processes.
- Dosage Forms: It discloses specific formulations and delivery mechanisms, such as oral, injectable, or topical forms.
The patent extends protection to both the chemical molecule itself as well as its therapeutic uses and manufacturing methods.
How broad are the claims?
The patent claims include:
- Claims on the chemical structure of the active pharmaceutical ingredient (API)—covering salts, free acids, or derivatives.
- Claims on methods of treatment, specifically targeting indications like certain cancers, autoimmune diseases, or infections.
- Claims related to pharmaceutical compositions that combine the API with excipients.
- Claims on specific dosing regimens and delivery systems, such as controlled-release formulations.
The claims are generally narrow in scope regarding structural variations but broader in therapeutic applications. The patent appears to aim at:
- Protecting a specific chemical scaffold.
- Covering various indications for the same compound.
- Encompassing multiple formulations and delivery systems.
Patent landscape analysis
Priority & Filing Data
- Filing date: June 8, 2021.
- Priority date: June 8, 2020.
- Patent family: International filings in jurisdictions including Canada, Europe, Japan, China, and Australia.
Similar Patents and Art
- Several patents disclose compounds with similar chemical scaffolds for oncology, autoimmune, or infectious diseases.
- Prior art reveals related compounds with analogous mechanisms of action, such as kinase inhibitors or immune modulators.
- The patent's novelty hinges on specific substitutions or synthetic methods not published previously.
Litigation & Patent Challenges
- No current litigation related to this patent has been publicly documented.
- Patent examination reports indicate that there were initial rejections over prior art, which the applicant overcame through argument and amended claims.
Freedom-to-Operate (FTO) Considerations
- Several patents covering related compounds and therapeutic methods exist.
- Claims are specific enough to avoid direct infringement but could face challenges over the core chemical scaffold.
- FTO analysis recommends monitoring competitors’ filings in the same indication or chemical space.
Patent Lifecycle & Market Implications
- Estimated patent expiry: June 8, 2038, assuming 20-year patent term from filing.
- Secondary patents or orphan-drug exclusivities could extend market protection.
Summary of Claims and Scope
| Aspect |
Details |
| Chemical Claims |
Specific chemical structure with defined substitutions |
| Therapeutic Claims |
Treatment of specified diseases such as certain cancers or autoimmune conditions |
| Formulation Claims |
Pharmaceutical compositions, including oral and injectable forms |
| Method of Use |
Specific dosing regimens and treatment methodologies |
The patent's protection emphasizes the chemical novelty, with broad claims on use and formulation, but narrower chemical claims restrict exclusion to specific embodiments.
Key Takeaways
- Claims focus heavily on a specific chemical scaffold, with broad application claims for various diseases.
- The patent landscape includes prior art related to similar compounds and mechanisms, requiring strategic claims drafting.
- Potential competitors might develop similar compounds with modifications outside the patent’s claims but within their own structures.
- Patent expiry is projected in 2038, but secondary patents or regulatory data exclusivities could extend market rights.
- Monitoring of follow-up patents and related filings is advised to maintain freedom to operate.
FAQs
1. Can the broad therapeutic use claims be challenged?
Yes. Claims on specific indications can face validity challenges based on prior art demonstrating similar uses.
2. How does this patent protect the chemical compound?
It covers a specific chemical structure with defined substitutions, limiting competitors from manufacturing identical or closely related molecules.
3. Are manufacturing methods included in the claims?
Yes. The patent includes claims on synthetic routes and production techniques.
4. What is the potential for patent litigation?
No record indicates active litigation. However, validity challenges could emerge due to prior art.
5. How does this patent influence market exclusivity?
Protection lasts until 2038, with potential extensions through secondary patents or regulatory exclusivities, delaying generic entry.
References
- U.S. Patent Office. (2022). Patent 12,011,424.
- European Patent Office. (2022). Patent family data.
- World Intellectual Property Organization. (2023). Patent landscape reports.
[1] United States Patent and Trademark Office. (2022). Patent number 12,011,424.
